Relaxin-2 for Heart Failure With Preserved Ejection Fraction: A Comment on the Termination of a Phase-II Trial Investigating the Relaxin-2 Analogue, LY3540378. Global Cardiol 2024, 2 (4). https://doi.org/10.4081/cardio.2024.56.